Clinical Trial

Gynecological Impact of Allogeneic Hematopoietic Stem Cell Transplantation in Adults

Study acronym: GYNEGRAFT
Completed
View on ClinicalTrials.gov →
Summary
Gynecological impact and infertility are major issues for women after allogeneic hematopoietic stem cell transplantation. The aim of the present study is to investigate the prevalence of gynecological complications after allogeneic hematopoietic stem cell transplantation for acute leukemia in adulthood. By conducting a single-center retrospective descriptive analysis, the prevalence, follow-up and treatment of gynecological complications -including premature ovarian failure, vulvovaginal graft-versus-host-disease, cervical pathology- will be analysed
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-06-24; most recent amendment 2026-06-24.
Status change: Recruiting → Completed 2026-06-24
Status change: Not Yet Recruiting → Recruiting 2025-12-09
Trial Details
NCT Number NCT07048730
Lead Sponsor University Hospital, Bordeaux
Conditions Acute Leukemia
Enrollment 51 participants
Start Date 2025-09-19
Primary Completion 2026-04-05 (estimated)
Study Completion 2026-04-05 (estimated)
Updated on ClinicalTrials.gov 2026-06-25